Literature DB >> 22528141

Psychiatrist decision-making towards prescribing benzodiazepines: the dilemma with substance abusers.

Carla Beth Marienfeld1, Ece Tek, Esperanza Diaz, Richard Schottenfeld, Marek Chawarski.   

Abstract

Psychiatrists' decision making about prescribing benzodiazepines (BZD) was evaluated in a community mental health center. An anonymous survey of outpatient psychiatrists in an academic-affiliated public mental health center was conducted using a 45-item questionnaire developed based on the results of a previous study. Sixty-six percent of responses indicate that, at times, psychiatrists experienced requests for behaviors suspicious for abuse, including 'lost/missing prescriptions' and 'use of BZD by others'. Patient characteristics such as 'history of abuse', 'unknown patient', and 'patient use of illicit substances' were occasional or common reasons for NOT prescribing BZDs (75%). The most common contexts in which the majority of our sample was uncomfortable prescribing BZDs involved a patient history of substance abuse, fear of initiation of dependence, diversion, and feeling manipulated by the patient. Time limitations were a dilemma for 20%. Psychiatrist self-reported dilemma and behavior in prescribing BZDs largely reflected concerns with substance abuse and less frequently workload or time issues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528141     DOI: 10.1007/s11126-012-9220-8

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  28 in total

Review 1.  Non-pharmacologic treatments for social anxiety disorder.

Authors:  T I Zaider; R G Heimberg
Journal:  Acta Psychiatr Scand Suppl       Date:  2003

Review 2.  Effectiveness of benzodiazepines: do they work or not?

Authors:  Malcolm Lader
Journal:  Expert Rev Neurother       Date:  2008-08       Impact factor: 4.618

3.  The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

Authors:  R C Kessler; C B Nelson; K A McGonagle; M J Edlund; R G Frank; P J Leaf
Journal:  Am J Orthopsychiatry       Date:  1996-01

4.  General practitioners' prescribing patterns of benzodiazepine hypnotics: are elderly patients at particular risk for overprescribing? A report from the Møre & Romsdal Prescription Study.

Authors:  J Straand; K Rokstad
Journal:  Scand J Prim Health Care       Date:  1997-03       Impact factor: 2.581

Review 5.  Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence.

Authors:  M A Posternak; T I Mueller
Journal:  Am J Addict       Date:  2001

6.  The long-term use of benzodiazepines: patients' views, accounts and experiences.

Authors:  G Barter; M Cormack
Journal:  Fam Pract       Date:  1996-12       Impact factor: 2.267

Review 7.  The pharmacologic treatment of anxiety disorders: a review of progress.

Authors:  Lakshmi N Ravindran; Murray B Stein
Journal:  J Clin Psychiatry       Date:  2010-07       Impact factor: 4.384

8.  Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.

Authors:  Robin E Clark; Haiyi Xie; Mary F Brunette
Journal:  J Clin Psychiatry       Date:  2004-02       Impact factor: 4.384

9.  Controversial issues associated with the prescription of benzodiazepines by general practitioners and psychiatrists.

Authors:  Carlos de las Cuevas; Emilio José Sanz
Journal:  Med Sci Monit       Date:  2004-06-29

Review 10.  Current use of benzodiazepines in anxiety disorders.

Authors:  Jean-Marc Cloos; Valérie Ferreira
Journal:  Curr Opin Psychiatry       Date:  2009-01       Impact factor: 4.741

View more
  1 in total

1.  Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study.

Authors:  Yi-Chien Hsu; Yu-Ching Chou; Hsin-An Chang; Yu-Chen Kao; San-Yuan Huang; Nian-Sheng Tzeng
Journal:  Neuropsychiatr Dis Treat       Date:  2015-01-27       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.